{
  "id": "clinical#screening_cues_3a2ce73a",
  "content": "• All diagnostic requirements for substance-induced mood disorder are met.\n• The presentation is characterized by both depressive and manic symptoms judged to be the\ndirect consequence of the use of or withdrawal from a specified substance or medication.\n6C4x.y0Z Substance-induced mood disorder, unspecified\nSubstance-induced anxiety disorders\nAvailable categories by substance class\n6C40.71 Alcohol-induced anxiety disorder\n6C41.71 Cannabis-induced anxiety disorder\n6C42.71 Synthetic cannabinoid-induced anxiety disorder\n6C43.71 Opioid-induced anxiety disorder\n6C44.71 Sedative, hypnotic or anxiolytic-induced anxiety disorder\n6C45.71 Cocaine-induced anxiety disorder\n6C46.71 Stimulant-induced anxiety disorder, including amfetamines, methamfetamine\nand methcathinone\n6C47.71 Synthetic cathinone-induced anxiety disorder\n6C48.40 Caffeine-induced anxiety disorder\n6C49.61 Hallucinogen-induced anxiety disorder\n6C4B.71 Volatile inhalant-induced anxiety disorder\n6C4C.71 MDMA or related drug-induced anxiety disorder, including MDA\n6C4D.61 Dissociative-induced anxiety disorder, including ketamine and PCP\n6C4E.71 Anxiety disorder induced by other specified psychoactive substance\n6C4F.71 Anxiety disorder induced by multiple specified psychoactive substances\n6C4G.71 Anxiety disorder induced by unknown or unspecified psychoactive substances\nEssential (required) features\n• The presentation is characterized by anxiety symptoms (e.g. apprehension or worry,\nfear, physiological symptoms of excessive autonomic arousal, panic attacks, avoidance\nbehaviour) that develop during or soon after intoxication with or withdrawal from a\nspecified substance, or use or discontinuation of a psychoactive medication.\n• The intensity or duration of the anxiety symptoms is substantially in excess of anxiety",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues • All diagnostic requirements for substance-induced mood disorder are met.\n• The presentation is characterized by both depressive and manic symptoms judged to be the\ndirect consequence of the use of or withdrawal from a specified substance or medication.\n6C4x.y0Z Substance-induced mood disorder, unspecified\nSubstance-induced anxiety disorders\nAvailable categories by substance class\n6C40.71 Alcohol-induced anxiety disorder\n6C41.71 Cannabis-induced anxiety disorder\n6C42.71 Synthetic cannabinoid-induced anxiety disorder\n6C43.71 Opioid-induced anxiety disorder\n6C44.71 Sedative, hypnotic or anxiolytic-induced anxiety disorder\n6C45.71 Cocaine-induced anxiety disorder\n6C46.71 Stimulant-induced anxiety disorder, including amfetamines, methamfetamine\nand methcathinone\n6C47.71 Synthetic cathinone-induced anxiety disorder\n6C48.40 Caffeine-induced anxiety disorder\n6C49.61 Hallucinogen-induced anxiety disorder\n6C4B.71 Volatile inhalant-induced anxiety disorder\n6C4C.71 MDMA or related drug-induced anxiety disorder, including MDA\n6C4D.61 Dissociative-induced anxiety disorder, including ketamine and PCP\n6C4E.71 Anxiety disorder induced by other specified psychoactive substance\n6C4F.71 Anxiety disorder induced by multiple specified psychoactive substances\n6C4G.71 Anxiety disorder induced by unknown or unspecified psychoactive substances\nEssential (required) features\n• The presentation is characterized by anxiety symptoms (e.g. apprehension or worry,\nfear, physiological symptoms of excessive autonomic arousal, panic attacks, avoidance\nbehaviour) that develop during or soon after intoxication with or withdrawal from a\nspecified substance, or use or discontinuation of a psychoactive medication.\n• The intensity or duration of the anxiety symptoms is substantially in excess of anxiety • all diagnostic requirements for substance-induced mood disorder are met. • the presentation is characterized by both depressive and manic symptoms judged to be the\ndirect consequence of the use of or withdrawal from a ..."
}